OMAHA- After more than 40 years in a variety of roles for Nebraska Medicine, UNMC, and the University of Nebraska, James Linder, MD, will step down as Nebraska Medicine CEO on Tuesday, July 1. Dr. Linder has held the CEO title since August 2018. The Nebraska Medicine Board of Directors unanimously chose Michael Ash, MD, to succeed him as the next chief executive officer of the private, nonprofit health system.

“Age 70 feels like a graceful time to step aside—creating space for a leader with a longer runway, while hopefully leaving me time to pursue interests outside of work,” says Dr. Linder. “There is tremendous uncertainty facing health care, but I have confidence that our organization is prepared to thrive in the next decade. As a nonprofit academic medical center, we have the people, knowledge, and culture to excel in our clinical, educational, and research missions.”

Dr. Linder says he and the board have been working on succession planning for the last several years, and the clinical, business, and leadership skills Dr. Ash brings to the role are the right fit at the right time.

For the full article click HERE